6-(Trifluoromethyl)pyridine-2-carboxylic acid methyl ester is a heterocyclic organic compound featuring a pyridine ring substituted with a trifluoromethyl group at the 6-position and a methyl ester at the 2-position. This structure combines the electron-withdrawing properties of the trifluoromethyl group with the versatile reactivity of the ester and the pyridine nitrogen. Its primary application is as a key pharmaceutical intermediate. The pyridine-2-carboxylate scaffold is a privileged structure in medicinal chemistry, and the introduction of the trifluoromethyl group is a common strategy to enhance metabolic stability, lipophilicity, and binding affinity of drug candidates. This specific compound serves as a crucial building block in the synthesis of various active pharmaceutical ingredients (APIs), particularly those targeting central nervous system disorders and other therapeutic areas. As a synthetic building block, it is used in cross-coupling reactions, hydrolysis to the corresponding acid, or further functionalization of the pyridine ring. Its well-defined structure makes it a valuable starting material for constructing more complex heterocyclic systems in drug discovery programs.